soul trial oral semaglutide cardiovascular outcomes results 2024 2025 Oral Semaglutide in High-Risk Type 2 Diabetes: Cardiovascular Benefit Confirmed in the SOUL Trial Clinical Effectiveness and Safety of – Oral Semaglutide Reduces Risk of

Researchers reviewing safety information should consider the full adverse event profile, including cardiovascular observations, discontinuation rates, laboratory measures and any serious adverse events reported in trial data

Traditional Japanese herbal medicine Yokukansan targets distinct but overlapping mechanisms in aged mice and in the 5xFAD mouse model of Alzheimers disease

For the aortic samples from aged mice, first, the aortas from different treatment groups were excised and other tissues were removed, leaving only the aortic endothelium

Using a 3 mL syringe for a 0.10 mL dose

Limitations include the low proportion of nonwhite participants and the preponderance of female participants